Changes in plasma luteinizing hormone levels and P4/E2 sex hormone ratios as a result of cetrorelix treatment (Fig 7). by Kalman F. Szucs (19353218)

Subjects:

One-way migration distances calculated as mid–point to mid–point of their summer and winter geographic ranges. by Hector Galbraith (636637)

Depletion of putative SDH subunits leads to decreased SDH activity and oxygen consumption. by Mariana F. Silva (10219520)

a) FB image processing featuring (1) FB map, (2) TWOMBLI mask, (3) FB-mask multiplied image, and (4) Ridge detection selection of contours. b) TWOMBLI Output Descriptions. (1) Area... by Zoë Dinkel (21402766)

<i>Kdm6a</i> knockdown causes a female-specific decrease in <i>Rhox6</i> and <i>9</i> expression in ES cells. by Joel B. Berletch (409334)

“…<p>(A) Quantitative RT-PCR after <i>Kdm6a</i> knockdown in female PGK12.1 ES cells shows a 75% and a 52% decrease in <i>Kdm6a</i> and <i>Rhox6</i> and <i>9</i> expression, respectively. …”

Biallelic mutations in human <i>HBS1L</i> lead to Hbs1L deficiency and decreased Pelota protein. by Amy E. O’Connell (6288401)

Quantitative PCR of RNA from lung cells demonstrates a decrease in negative regulators of Th1 immunity in Mtb challenged vaccinated rats. by Amit Singhal (193686)

TLR agonists decrease ZIKV replication. by Fiorella Rossi (134126)

Genes showing ≥3-fold differences in expression level in IgG4-RD patients and healthy controls. by Akio Nakajima (301253)

“…<p>We identified 21 genes showing a ≥3-fold increase (16 genes) or decrease (5genes) in expression level among 4 samples from 4 healthy controls and 2 IgG4-RD patients before and after therapy.…”

DataSheet_1_Failure to decrease HbA1c levels following TB treatment is associated with elevated Th1/Th17 CD4+ responses.pdf by Robert Krause (504842)

“…</p>Results<p>CD62 P-selectin was up- (1.5-fold) and IL-10 downregulated (0.85-fold) in plasma among individuals whose HbA1c remained stable/increased during TB treatment. …”

Mutations affecting the Pho regulon can decrease stress-induced Lac⁺ reversion. by Janet L. Gibson (736950)

“…Strains (top to bottom in legend): SMR5235, SMR4953, SMR4059, SMR7351, SMR6762, SMR6760, SMR6759, SMR4061, SMR5860, SMR4047, and SMR4604. Fold decrease in the change in Lac⁺ from day 4 to day 5 relative to the <i>pho</i>⁺ strain SMR4562 was calculated for each genotype in several experiments of multiple cultures (like that shown in A). …”

ZEBRA and BGLF5 decrease levels of GFP mRNA and protein; one point mutant of ZEBRA does not inhibit GFP expression. by Richard Park (547667)

Increased AQP2 expression by a vasopressin analogue is decreased by NOX4 depletion in mpkCCD_cl4 cells. by Eric Féraille (513934)

Plasma from ATTR individuals presents a higher proteolytic activity. by Gonçalo da Costa (198731)

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

Chronic high glucose induces apoptosis and proteasome activities decrease in INS-1E cells. by Christophe Broca (538652)

Effect of decreased RASSF6 expression on gene expression in 3T3-L1 adipocytes. by Yohei Sanada (405736)

Concentration-dependent i⁶A37 modification of cy-tRNA^TrpCCA. by Abdul Khalique (5029442)

Gene ontology biological processes overrepresented among genes exhibiting decreased expression in human psoriasis. by William R. Swindell (175427)

“…<p>A total of 3540 transcripts were identified as significantly decreased in psoriatic plaques obtained from human patients relative to normal skin obtained from control subjects (FDR-adjusted P<0.05 and log₂-transformed fold-change less than -0.50). …”

Belinostat decreases both male and female bladder weights in transgenic superficial bladder cancer mice by Michael T Buckley (37161)

“…Normal non-transgenic mouse bladders weigh approximately 10.0 mg at the same age, and Ha-transgenic mice with superficial bladder cancer have a 3 fold and higher bladder weight. , Male belinostat-treated mice (n = 4, 327.5 mg average weight) showed a two-fold decrease (50%, p = 0.03) in bladder weight versus control (n = 4, 652.5 mg average weight). , Female belinostat-treated mice (n = 5, 34.0 mg average weight) showed a 36% decrease (p = 0.04) in bladder weight versus control (n = 6, 53.3 mg average weight).…”